Abstract
To assess the ability of non-invasive cardiac output monitoring (NICOM), a novel method of non-invasive maternal hemodynamic assessment using bioreactance, in combination with first trimester biomarkers to predict the evolution of gestational hypertension (GH), pre-eclampsia (PE) and normotensive fetal growth restriction (FGR).
Original language | English |
---|---|
Pages (from-to) | S207-S207 |
Journal | American Journal of Obstetrics and Gynecology |
Volume | 218 |
Issue number | 1 |
DOIs | |
Publication status | Published - 1 Jan 2018 |
Externally published | Yes |
Keywords
- non-invasive cardiac output monitoring
- NICOM
- non-invasive maternal hemodynamic assessment
- bioreactance
- first trimester biomarkers
- gestational hypertension
- GH
- pre-eclampsia
- PE
- normotensive fetal growth restriction
- FGR